Erythrocyte methotrexate polyglutamate concentrations in patients with Crohn's Disease: towards a new therapeutic drug monitoring tool

被引：0
|
作者：
de Meeberg, M. Van [1 ]
Lin, M. [2 ]
Seinen, M. [3 ]
Fidder, H. [4 ]
Oldenburg, B. [4 ]
Bouma, G. [1 ]
de Jonge, R. [2 ]
Calasan, M. Bulatovic [5 ]
机构：
[1] Amsterdam UMC, Dept Gastroenterol, Amsterdam, Netherlands
[2] Amsterdam UMC, Dept Clin Chem, Amsterdam, Netherlands
[3] OLVG, Dept Gastroenterol, Amsterdam, Netherlands
[4] UMC Utrecht, Dept Gastroenterol, Utrecht, Netherlands
[5] UMC Utrecht, Dept Rheumatol Clin Immunol, Utrecht, Netherlands
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
10.1093/ecco-jcc/jjab076.436
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P312
引用
收藏
页码：S339 / S339
页数：1
相关论文
共 50 条
  • [1] Methotrexate Polyglutamate Monitoring in Patients With Crohn's Disease
    Fischer, Monika
    Siva, Shivi
    Cook, Gwendolyn K.
    Jones, David R.
    Fadda, Hala M.
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (03): : 240 - 245
  • [2] Therapeutic drug monitoring of methotrexate in patients with Crohn's disease
    van de Meeberg, Maartje M.
    Fidder, Herma H.
    Oldenburg, Bas
    Sundaresan, Janani
    Struys, Eduard A.
    Montazeri, Nahid S. M.
    Mares, Wout G. N.
    Mahmmod, Nofel
    van Asseldonk, Dirk P.
    Lutgens, Maurice W. M. D.
    Kuyvenhoven, Johan P.
    Rietdijk, Svend T.
    Nissen, Loes H. C.
    Koehestanie, Parweez
    de Boer, Nanne K. H.
    de Jonge, Robert
    Bouma, Gerd
    Calasan, Maja Bulatovic
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (11-12) : 1151 - 1162
  • [3] Methotrexate Polyglutamate Concentrations in Erythrocytes Are a Potential Tool for Therapeutic Drug Monitoring of Methotrexate Response in Rheumatoid Arthritis.
    De Rotte, C. F. J.
    den Boer, Ethan
    Bulatovic, Maja
    Pluijm, Saskia M. F.
    Hazes, Johanna M. W.
    De Jonge, Robert
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S914 - S914
  • [4] Therapeutic drug monitoring in Crohn's disease
    Baker, Holly
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (03): : 150 - 150
  • [5] Proactive Therapeutic Drug Monitoring of Adalimumab in Patients With Crohn's Disease
    Papamichael, Konstantinos
    Dubinsky, Marla C.
    Cheifetz, Adam S.
    [J]. GASTROENTEROLOGY, 2023, 164 (01) : 164 - 165
  • [6] Therapeutic drug monitoring of methotrexate and its polyglutamated metabolites erythrocyte concentrations in rheumatoid arthritis
    Verdier, M.
    Rihouey, D.
    Bentue-Ferrer, D.
    Perdriger, A.
    Bellissant, E.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 72 - 72
  • [7] Therapeutic Drug Monitoring of Biologics in Crohn?s Disease
    Grossberg, Laurie B.
    Cheifetz, Adam S.
    Papamichael, Konstantinos
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2022, 51 (02) : 299 - 317
  • [8] Update on Therapeutic Drug Monitoring in Crohn's Disease
    Heron, Valerie
    Afif, Waqqas
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2017, 46 (03) : 645 - +
  • [9] Key insights from therapeutic drug monitoring in Crohn's disease patients
    Seinen, Margien L.
    De Boer, Nanne K.
    van Bodegraven, Adriaan A.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (05) : 399 - 406
  • [10] Ustekinumab therapeutic drug monitoring in Crohn's disease patients with loss of response
    Heron, V.
    Bessissow, T.
    Bitton, A.
    Lakatos, P.
    Seidman, E.
    Jain, A.
    Battat, R.
    Germain, P.
    Lemieux, C.
    Afif, W.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S379 - S380
12345